Targeting PECAM-1 for anti-cancer therapy

Cancer Biology and Therapy

Volumn 6, Issue 1, 2007, Pages 121-122

  DeLisser, Horace M ^a  

^a SVM Hill Pavilion   (United States)

Author keywords

Angiogenesis; Apoptosis; Endothelial cells; Macrophages; PECAM 1; Tumor microenvironment

Indexed keywords

CD31 ANTIGEN; MONOCLONAL ANTIBODY; PLATELET ENDOTHELIAL CELL ADHESION MOLECULE 1 ANTIBODY; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; BLOOD VESSEL PERMEABILITY; CANCER INHIBITION; DRUG MECHANISM; DRUG SAFETY; DRUG TARGETING; GENOTOXICITY; LYMPHOMA; NOTE; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 33847162125     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.6.1.3827     Document Type: Note

References (23)

1. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001; 411:375-9.
2. Mueller MM, Fusenig NE. Friends or foes - bipolar effects of the tumour stroma in cancer. Nature Reviews Cancer, 2004; 4:839-49.
3. Dirkx AE, oude Egbrink MG, Wagstaff J, Griffioen AW. Monocyte/macropahge infiltration in tumors:,odulators of angiogenesis. FASEB J 2006; 20:621-30.
4. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nature Reviews Cancer 2004; 4:71-8.
5. McDonald DM, Baluk P. Significance of blood vessel leakiness in cancer. Cancer Res 2002; 62:5381-5.
6. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005; 307:58-62.
7. Newman PJ, Newman DK. Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol 2003; 23:953-64.
8. lan N, Madri JA. PECAM-1: old friend, new partners. Curr Opin in Cell Biol 2003; 15:515-24.
9. Jackson DE. The unfolding tale of PECAM-1. FEBS Lett 2003. 540:7-14.
10. DeLisser HM, Christofidou-Solomidou M, Strieter RM, Burdick MD, Robinson CS, Wexler RS, Kerr JS, Garlanda C, Merwin JR, Madri JA, Albelda SM. Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol 1997; 151:671-77.
11. Zhou Z, Christofidou-Solomidou M, Garlanda C, DeLisser HM. Antibody against murine PECAM-1 inhibits tumor angiogenesis in mice. Angiogenesis 1999; 3:181-8.
12. Cao G, O'Brien CD, Zhou Z, Sanders SM, Greenbaum JN, Makrigiannakis A, DeLisser HM. Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration. Am J Physiol Cell Physiol 2002; 282:C1181-90.
13. Solowiej A, Biswas P, Graesser D, Madri JA. Lack of platelet endothelial cell adhesion molecule-1 attenuates foreign body inflammation because of decreased angiogenesis. Am J Pathol 2003; 162:953-62.
14. Graesser D, Solowiej A, Bruckner M, Osterweil E, Juedes A, Davis S, Ruddle NH, Engelhardt B, Madri JA. Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J Clin Investig 2002; 109:383-92.
15. Nakada MT, Amin K, Christofidou-Solomidou M, O'Brien CD, Sun J, Gurubhagavatula I, Heavner GA, Taylor AH, Paddock C, Sun QH, Zehnder JL, Newman PJ, Albelda SM, DeLisser HM. Antibodies against the first Ig-like domain of human platelet endothelial cell adhesion molecule-1 (PECAM-1) that inhibit PECAM-1-dependent homophilic adhesion block in vivo neutrophil recruitment. J Immunol 2000; 164:452-62.
16. Schenkel AR, Chew TW, Muller WA. Platelet endothelial cell adhesion molecule deficiency or blockade significantly reduces leukocyte emigration in a majority of mouse strains. J Immunol 2004; 173:6403-8.
17. Wang S, Dangerfield JP, Young RE, Nourshargh S. PECAM-1, alpha6 integrins and neutrophil elastase cooperate in mediating neutrophil transmigration. J Cell Sci 2005; 118:2067-76.
18. Carrithers M, Tandon S, Canosa S, Michaud M, Graesser D, Madri JA. Enhanced susceptibility to endotoxic shock and impaired STAT3 signaling in CD31-deficient mice. Am J Pathol 2005; 166:185-96.
19. Maas M, Stapleton M, Bergom C, Mattson DL, Newman DK, Newman PJ. Endothelial cell PECAM-1 confers protection against endotoxic shock. Am J Physiol - Heart Circ Physiol 2005; 288:H159-64.
20. Gao C, Sun W, Christofidou-Solomidou M, Sawada M, Newman DK, Bergom C, Albelda SM, Matsuyama S, Newman PJ. PECAM-1 functions as a specific and potent inhibitor of mitochondrial-dependent apoptosis. Blood 2003; 102:169-79.
21. Bergom C, Goel R, Paddock C, Gao C, Newman DK, Matsuyama S, Newman PJ. The Cell-Adhesion and Signaling Molecule PECAM-1 is a Molecular Mediator of Resistance to Genotoxic Chemotherapy. Cancer Biol Ther 2006; 5:1699-707.
22. Bergom C, Gao C, Newman PJ. Mechanisms of PECAM-1-mediated cytoprotection and implications for cancer cell survival. Leuk Lymphoma; 46:1409-21.
23. Duncan GS, Andrew DP, Takimoto H, Kaufman SA, Yoshida H, Spellberg J, Luis de la Pompa J, Elia A, Wakeham A, Karan-Tamir B, Muller WA, Senaldi G, Zukowski MM, Mak TW. Genetic evidence for functional redundancy of Platelet/Endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J Immunol 1999; 162:3022-30.